- Home
- LPSN vs RPTX Comparison
LPSN vs RPTX Comparison
Compare LPSN & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- RPTX
- Stock Information
- Founded
- LPSN 1995
- RPTX 2016
- Country
- LPSN United States
- RPTX Canada
- Employees
- LPSN N/A
- RPTX N/A
- Industry
- LPSN EDP Services
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- RPTX Health Care
- Exchange
- LPSN Nasdaq
- RPTX Nasdaq
- Market Cap
- LPSN 72.8M
- RPTX 63.9M
- IPO Year
- LPSN 2000
- RPTX 2020
- Fundamental
- Price
- LPSN $0.74
- RPTX $1.41
- Analyst Decision
- LPSN Hold
- RPTX Strong Buy
- Analyst Count
- LPSN 3
- RPTX 3
- Target Price
- LPSN $1.20
- RPTX $4.50
- AVG Volume (30 Days)
- LPSN 833.9K
- RPTX 94.4K
- Earning Date
- LPSN 07-30-2025
- RPTX 08-05-2025
- Dividend Yield
- LPSN N/A
- RPTX N/A
- EPS Growth
- LPSN N/A
- RPTX N/A
- EPS
- LPSN N/A
- RPTX N/A
- Revenue
- LPSN $292,025,000.00
- RPTX $1,073,000.00
- Revenue This Year
- LPSN N/A
- RPTX N/A
- Revenue Next Year
- LPSN $0.82
- RPTX N/A
- P/E Ratio
- LPSN N/A
- RPTX N/A
- Revenue Growth
- LPSN N/A
- RPTX N/A
- 52 Week Low
- LPSN $0.53
- RPTX $0.89
- 52 Week High
- LPSN $2.08
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- LPSN 45.79
- RPTX 51.83
- Support Level
- LPSN $0.68
- RPTX $1.33
- Resistance Level
- LPSN $0.79
- RPTX $1.48
- Average True Range (ATR)
- LPSN 0.05
- RPTX 0.05
- MACD
- LPSN 0.00
- RPTX -0.01
- Stochastic Oscillator
- LPSN 40.29
- RPTX 34.37
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.